Social media

Looking forward to #ASCPT2026. Come along to the ICON partner hub for a chat and don’t miss our Learning Lab session on 5th March at 10:30 where we will be discussing considerations for the design, safety, pharmacokineti...

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine have developed PLATO 11, a validated, patient centred PRO tool designed to better capture the lived experience of people with obstructive sleep a...

When patients lead, progress follows. Join ICON’s Centre for Rare Diseases for a special Rare Disease Day webinar exploring how patient and parent leaders are breaking barriers in ultra rare disease drug development. F...

Managing AI model biases in SaMD is no longer optional - it’s essential. As AI enabled medical devices accelerate through FDA authorisation, developers must ensure their models don’t unintentionally reinforce healthcare ...

Artificial intelligence is transforming how life sciences teams plan, execute, and scale commercial strategy—but the true differentiator isn’t the algorithm. It’s the data foundation behind it. In our latest blog, we ex...

The future of patient safety is being shaped today by experts who combine scientific rigour with innovation. Hassan Aljobori, Pharmacovigilance Director at ICON, discusses global collaboration, the role of emerging te...

Heart failure is one of the leading causes of hospitalisation among adults over 65. Cardiovascular outcome trials can be complex and costly. Find out how considering the human element of CVOTs, and building appropriate...

With trial complexity and costs rising, sponsors are shifting from WHETHER to use DHTs to HOW to integrate them responsibly and at scale. With regulators like the FDA and EMA actively encouraging patient-centric and real...

In this article, our data standards experts Kent Letourneau and Sandra Minjoe explain how sponsors can efficiently prepare clinical data submissions that meet both FDA and PMDA requirements, by leveraging the substantial...

PLATO 11 is a new, validated, freely accessible PRO instrument developed by ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine to fill a critical gap in patient centred assessment for obstructive ...

1 in 5 people will develop heart failure in their lifetime. ICON recognises the importance to raise global awareness of heart failure risk factors such as hypertension, obesity, diabetes and coronary heart disease. Dis...